Back to mobile site

Praxis Precision Medicines Inc. (PRAX) PT Raised to $500 at Truist Securities

December 8, 2025 6:26 AM EST Send to a Friend
Truist Securities analyst Joon Lee raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $500.00 (from $360.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login